Antimicrobial compositions and methods of use
The present invention relates to antimicrobial compositions and methods for their use. In particular, the compositions comprise an antimicrobial agent and a nanostructured liquid crystal carrier, wherein the antimicrobial agent is contained within the nanostructured liquid crystal carrier, and wherein the nanostructured liquid crystal carrier potentiates the activity of the antimicrobial agent. Antimicrobial agents encompassed by the present invention include cationic antibiotics, antimicrobial peptides, and antifungal agents. Nanostructured liquid crystal carriers encompassed by the present invention include those formed from an amphiphilic lipid such as monoolein and phytantriol. Antimicrobial compositions encompassed by the present invention can be used for the treatment or prevention of a microbial infection, such as that caused by a Gram-negative bacterium, including where the microbial infection forms part of a biofilm. The present invention also relates to methods for reducing the viability of a microorganisms, for potentiating the activity of an antimicrobial agent, for reducing the dose of an antimicrobial agent required to treat or prevent a microbial infection, or for increasing the potency of an antimicrobial agent required to treat or prevent a microbial infection, by administering an antimicrobial composition described herein. Kits comprising the antimicrobial compositions are also encompassed by the present invention.
1 . An antimicrobial composition comprising:
(i) an antimicrobial agent; and
(ii) a nanostructured liquid crystal carrier,
wherein the antimicrobial agent is contained within the nanostructured liquid crystal carrier, and wherein the nanostructured liquid crystal carrier potentiates the activity of the antimicrobial agent.
2 . The antimicrobial composition of claim 1 , wherein the nanostructured liquid crystal carrier comprises liquid crystal nanoparticles formed from a lipid in a non-lamellar liquid crystalline structure in an aqueous solvent.
3 . The antimicrobial composition of claim 2 , wherein the liquid crystal nanoparticles are formed from an amphiphilic lipid.
4 . The antimicrobial composition of claim 3 , wherein the amphiphilic lipid is selected from monoolein or phytantriol.
5 . The antimicrobial composition of claim 2 , wherein the liquid crystal nanoparticles have a particle size of about 50 nm to about 500 nm.
6 . The antimicrobial composition of claim 1 , wherein the antimicrobial agent is one or more of a cationic antibiotic, aminoglycoside antibiotic, antimicrobial peptide, and an antifungal agent.
7 . The antimicrobial composition of claim 6 , wherein the aminoglycoside antibiotic is selected from one or more of tobramycin, amikacin, gentamicin, kanamycin, neomycin, netilmicin, paromomycin, streptomycin, plazomicin and spectinomycin.
8 . The antimicrobial composition of claim 6 , wherein the cationic antibiotic is colistin.
9 . The antimicrobial composition of claim 1 , wherein the antimicrobial agent is contained within the nanostructured liquid crystal carrier at an equal volume to weight ratio to the lipid, or is contained within the nanostructured liquid crystal carrier at a concentration up to about 25% (w/w) of the lipid.
10 . The antimicrobial composition of claim 1 , wherein the microbial infection is a bacterial infection which is due to a Gram-negative bacterium.
11 . The antimicrobial composition of claim 1 , wherein the composition is in the form of a liquid, a gel, a suspension, a solid, a semi-solid, or a powder.
12 . The antimicrobial composition of claim 1 , wherein the composition is formulated for topical administration, parenteral administration, administration by inhalation, and oral administration.
13 . The antimicrobial composition of claim 12 , wherein the composition is administered by inhalation using a nebulizer or dry powder inhaler.
14 . The antimicrobial composition of claim 1 , wherein the antimicrobial agent is an aminoglycoside antibiotic selected from one or more of tobramycin, gentamicin, or amikacin, and the nanostructured liquid crystal carrier comprises liquid crystal nanoparticles formed from monoolein or phytantriol.
15 . A method for the treatment or prevention of a microbial infection in a subject, the method comprising administering to the subject an effective amount of an antimicrobial composition comprising:
(i) an antimicrobial agent; and
(ii) a nanostructured liquid crystal carrier,
wherein the antimicrobial agent is contained within the nanostructured liquid crystal carrier, and wherein the nanostructured liquid crystal carrier potentiates the activity of the antimicrobial agent.
16 . The method of claim 15 , wherein the microbial infection forms part of a biofilm in a subject or is in a planktonic state in a subject.
17 . The method of claim 15 , wherein the subject has become resistant or tolerant to the antimicrobial agent when administered in the absence of the nanostructured liquid crystal carrier.
18 . The method of claim 15 , wherein the bacterial infection is associated with cystic fibrosis sinopulmonary infections.
19 . The method of claim 18 , wherein the antimicrobial agent is an aminoglycoside antibiotic selected from one or more of tobramycin, gentamicin, or amikacin, and the nanostructured liquid crystal carrier comprises liquid crystal nanoparticles formed from monoolein or phytantriol.
20 . A kit for the treatment or prevention of a microbial infection in a subject, wherein the kit comprises an antimicrobial composition comprising:
(i) an antimicrobial agent; and
(ii) a nanostructured liquid crystal carrier,
wherein the antimicrobial agent is contained within the nanostructured liquid crystal carrier, and wherein the nanostructured liquid crystal carrier potentiates the activity of the antimicrobial agent.